$SNDX

$13.69 +$0.47 (3.56%) Close

$SNDX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$SNDX Management Team

Mr. Dennis Podlesak

Independent Chairman of the Board

Age 67

Compensation $954.4K USD

Sex Male

Mr. Michael Metzger

Chief Executive Officer

Director

Age 54

Compensation $7.707M USD

Sex Male

Mr. Keith Goldan

Chief Financial Officer

Age 54

Compensation $2.824M USD

Sex Male

Mr. Luke Albrecht

General Counsel

Secretary

Age 46

Compensation $2.470M USD

Sex Male

Mr. Steven Closter

Chief Commercial Officer

Age 56

Compensation $3.557M USD

Sex Male

Mr. Nicholas Botwood

Head - Research and Development

Chief Medical Officer

Age -

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Dennis Podlesak Independent Chairman of the Board	67	$954.4K USD	Male
Mr. Michael Metzger Chief Executive Officer Director	54	$7.707M USD	Male
Mr. Keith Goldan Chief Financial Officer	54	$2.824M USD	Male
Mr. Luke Albrecht General Counsel Secretary	46	$2.470M USD	Male
Mr. Steven Closter Chief Commercial Officer	56	$3.557M USD	Male
Mr. Nicholas Botwood Head - Research and Development Chief Medical Officer	-	-	Male

Board of Directors

From the proxy statement filed Apr 30, 2026

Directors

serving now

Independent

6 of 7

stated in the proxy

Average tenure

8.3 years

from year joined

CEO also chairs the board

Dennis G. Podlesak

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Pierre Legault	Not stated	2017 9 years	Independent	None stated	None stated	$503,750
Michael A. Metzger CEO	Not stated	2019 7 years	Not independent	None stated	Pyxis Oncology	Paid as CEO
Martin H. Huber, M.D.	66	2021 5 years	Independent	None stated	None stated	$433,750
Jennifer Jarrett	55	2018 8 years	Independent	None stated	Damora, Sagimet Biosciences, Zura Bio	$433,750
Keith A. Katkin	54	2017 9 years	Independent	None stated	Eledon Pharmaceuticals, Inc., Emergent BioSolutions, Inc.	$511,250
Dennis G. Podlesak Board chair	68	2008 18 years	Independent	None stated	None stated	$947,000
Aleksandra Rizo, M.D., Ph.D.	51	2024 2 years	Independent	None stated	None stated	$426,250

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 30, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$SNDX Management Team

Mr. Dennis Podlesak

Mr. Michael Metzger

Mr. Keith Goldan

Mr. Luke Albrecht

Mr. Steven Closter

Mr. Nicholas Botwood

Board of Directors

Related-party transactions

No related-party transactions disclosed